The authors evaluated the effects of racial residential segregation on the health of Black youth with type 1 diabetes. The study looked at the effects of living in highly segregated neighborhoods on HbA1c, while controlling for factors such as age, insulin delivery method, family income, and other aspects of adversity in the neighborhood. The researchers found that higher levels of racial residential segregation were associated with higher HbA1c even after controlling for family income and neighborhood adversity.
“The study demonstrates the influence of social determinants of health on health outcomes in youth of color with type 1 diabetes,” Ellis said. “It shows the importance for health care providers to ask about and address factors that affect youths’ diabetes health beyond daily diabetes management.”
One author disclosed financial ties to Boehringer Ingelheim.
ADA: Diabetes May Quadruple Risk for Long COVID
WEDNESDAY, June 8, 2022 (HealthDay News) — Diabetes may increase the risk for long COVID symptoms fourfold, according to research presented at the annual meeting of the American Diabetes Association, held from June 3 to 7 in New Orleans.
ADA: Insulin Delivery Systems Compared in Type 1 Diabetes
WEDNESDAY, June 8, 2022 (HealthDay News) — An open-source automated insulin delivery system appears to be safe and effective for use in people with type 1 diabetes, according to a study presented at the annual meeting of the American Diabetes Association, held from June 3 to 7 in New Orleans.
ADA: Once-Weekly Dulaglutide Ups Glycemic Control in Youth With T2D
TUESDAY, June 7, 2022 (HealthDay News) — For youth with type 2 diabetes, dulaglutide is superior to placebo for reducing mean glycated hemoglobin level, according to a study published online June 4 in the New England Journal of Medicine to coincide with the annual meeting of the American Diabetes Association, held from June 3 to 7 in New Orleans.
ADA: Once-Weekly Tirzepatide Yields Lasting Weight Loss in Obesity
TUESDAY, June 7, 2022 (HealthDay News) — For individuals with obesity, tirzepatide is associated with lasting weight loss, according to a study published online June 4 in the New England Journal of Medicine to coincide with the annual meeting of the American Diabetes Association, held from June 3 to 7 in New Orleans.
ADA: Elevated BMI in Adolescence Linked to T1D in Young Adulthood
MONDAY, June 6, 2022 (HealthDay News) — Elevated body mass index in adolescence is associated with an increased risk for type 1 diabetes in young adulthood, according to a study published online June 5 in Diabetologia to coincide with the annual meeting of the American Diabetes Association, held from June 3 to 7 in New Orleans.
ADA: Tirzepatide Improves Kidney Outcomes in T2DM With Increased CV Risk
Previous COVID-19 Tied to Increased Risk for Kidney Disease 
Predictors of Prediabetes/T2DM Identified Among U.S. Adolescents 
Differences in Cardiovascular Risk Factor Prevalence ID"d for South Asian Adults 
Sex Hormones Linked to Cardiovascular Events in Men With Type 2 Diabetes 
Bariatric Surgery Tied to Improvement in Performing Household Tasks 
Weight Regain Seen After Cessation of GLP-1 Receptor Agonists in Adults With Overweight, Obesity 
Satisfaction With Semaglutide Driven by Effective Weight Loss 
Intermittent Fasting Seems to Have Little to No Effect for Adults With Overweight, Obesity 
